Single names, sectors, valuations and the trades behind the tape, explained in plain language.

Eli Lilly is negotiating to buy AtaiBeckley, a psychedelic drug developer, for over $2 billion, Bloomberg reports. AtaiBeckley shares jumped

Angelini Pharma has completed its $4.1 billion acquisition of Catalyst Pharmaceuticals, paying $31.50 per share. The deal was funded with €1

Hero MotoCorp is entering Germany through a partnership with KSR Group, selling premium models like the XPulse 200 4V across 28+ sales and s

UAE telecom group e& is selling its entire 16.2% stake in Vodafone for nearly $6 billion and reviewing non-core investments under new CEO Ma

Seven & i, the Japanese owner of 7-Eleven, is reportedly in late-stage talks to acquire a double-digit stake in Poland's Zabka Group. The de

Berenberg trimmed its forecasts for travel retailer Avolta after a softer second quarter, cutting its price target to 56 francs from 59. The

Bank of America upgraded Imperial Brands to buy, saying Australia's drag on earnings is fading. Australia now represents only about 1% of re

UK homewares retailer Dunelm lifted sales 2.9% to £428 million in the April-June quarter, helped by a heatwave that drove online garden buys

EQT has raised its takeover bid for Japanese price-comparison site Kakaku.com to 3,440-3,460 yen per share, surpassing a competing offer fro

Italy's Angelini Pharma has completed its $4.1 billion all-cash takeover of Catalyst Pharmaceuticals, with €1 billion from state investor CD

Telenor shares fell 12% after the Norwegian telecom operator missed earnings expectations and cut its 2026 outlook. The company cited slower

RBC Capital Markets expects Rio Tinto to keep its 2026 outlook unchanged when it reports first-half results on July 28. The bank trimmed its